Barbato F. Vital
C.p. 19031
Curitiba, PR 81531980, Brazil
Curitiba, PR 81531980, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Phytotherapy in psychiatry: why psychiatrists should know about it.
Journal: Acta neuropsychiatrica
Published: October 02, 2024
Proteomic Analysis of a Rat Streptozotocin Model Shows Dysregulated Biological Pathways Implicated in Alzheimer's Disease.
Journal: International journal of molecular sciences
Published: January 23, 2024
Neuroscience-based nomenclature (NbN): the Portuguese version of the new classification for psychopharmacological drugs.
Journal: Trends in psychiatry and psychotherapy
Published: November 21, 2023
Ketamine reversed short-term memory impairment and depressive-like behavior in animal model of Parkinson's disease.
Journal: Brain research bulletin
Published: September 02, 2020
Anxiety-like behavior induced by 6-OHDA animal model of Parkinson's disease may be related to a dysregulation of neurotransmitter systems in brain areas related to anxiety.
Journal: Behavioural brain research
Published: December 23, 2018
Agomelatine's effect on circadian locomotor rhythm alteration and depressive-like behavior in 6-OHDA lesioned rats.
Journal: Physiology & behavior
Published: December 22, 2017
Effects of ketamine on vocal impairment, gait changes, and anhedonia induced by bilateral 6-OHDA infusion into the substantia nigra pars compacta in rats: Therapeutic implications for Parkinson's disease.
Journal: Behavioural brain research
Published: December 04, 2017
Pioglitazone reduces mortality, prevents depressive-like behavior, and impacts hippocampal neurogenesis in the 6-OHDA model of Parkinson's disease in rats.
Journal: Experimental neurology
Published: July 20, 2017
PPAR-γ agonist pioglitazone reduces microglial proliferation and NF-κB activation in the substantia nigra in the 6-hydroxydopamine model of Parkinson's disease.
Journal: Pharmacological reports : PR
Published: April 25, 2017
Opposite effects of bone marrow-derived cells transplantation in MPTP-rat model of Parkinson's disease: a comparison study of mononuclear and mesenchymal stem cells.
Journal: International journal of medical sciences
Published: December 20, 2013
PPAR-α agonist fenofibrate protects against the damaging effects of MPTP in a rat model of Parkinson's disease.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: September 15, 2013
Last Updated: 09/26/2026